Ryan Specialty names diversity head
Company's chief compliance officer steps into newly created role
Source: insurancebusinessmag.com
📰 Patrickg Ryan News
Page 6 - Patrickg Ryan News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Patrickg Ryan. Real-time updates on events, politics, business and more.
GOP Leaders Quiet amid Weak Voter Support on Immigration Issues
Biden's easy-migration border policy is very unpopular among swing voters -- but they are not committed to voting for the GOP in 2022.
Source: breitbart.com
GOP Leaders Quiet amid Weak Voter Support on Immigration Issues
Biden's easy-migration border policy is very unpopular among swing voters -- but they are not committed to voting for the GOP in 2022.
Source: breitbart.com
Ryan Specialty names new CIO
Exec has a long history of establishing IT excellence, CEO says
Source: insurancebusinessmag.com
People Moves: Former Lexington Exec Heads to FutureProof; Hourly.io Hires From Markel; Leisz Joins Nationwide E&S; New CIO at Ryan Specialty
San Diego-based FutureProof Technologies has hired Joseph Strickland as head of underwriting. He was previously senior vice president at AIG's Lexington
Source: insurancejournal.com
Shinnecock Indian Nation Breaks Ground on Cannabis Dispensary
Future plans include a cultivation facility and consumption lounge.
New York United States Chenae Bullock Shinnecock Indian Patrickg Ryan Shinnecock Cannabis Regulatory Division
Source: longisland.com
Scientists discover potential treatment for ALS
NU-9 – now called AKV9 could be more effective than anything else on the market currently used to treat ALS.
Source: abc15.com
New ALS 'drug' is more effective than existing ones
New research on the experimental drug, NU-9, invented and developed by two Northwestern University scientists to treat ALS (amyotrophic lateral sclerosis), shows it is more effective than existing FDA-approved drugs for the disease.
Source: northwestern.edu
Experimental drug more effective than existing FDA-approved medications for ALS
New research on the experimental drug, NU-9, invented and developed by two Northwestern University scientists to treat ALS (amyotrophic lateral sclerosis), shows it is more effective than existing FDA-approved drugs for the disease.
Patrickg Ryan P Hande Ozdinler Richardb Silverman Emily Henderson Northwestern University Northwestern University Feinberg School Of Medicine
Source: news-medical.net
Pfizer booster OK'd for kids 5-11 • How a Roe repeal might play out on campus • Health care high on top public companies list
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
Source: chicagobusiness.com